Carbon Monoxide-Related Vision Loss in an Acute Burn Patient | Canada Hyperbarics Skip to main content
Case Report J Burn Care Res 2024

Carbon Monoxide-Related Vision Loss in an Acute Burn Patient

Setia K, Newsom M, Hashimi H, Collins J, Senthil-Kumar P, Feldman M — J Burn Care Res, 2024

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Doctors reported the case of a 32-year-old man who developed cortical blindness after carbon monoxide (CO) poisoning from smoke inhalation in an apartment fire, and was treated with HBOT.

What They Found

MRI confirmed cerebral hypoperfusion (reduced blood flow to the brain) as the cause of his blindness. After HBOT treatment, the patient experienced partial recovery of his vision. The case highlights a rare but serious neurological complication of CO poisoning that HBOT may help address.

Canadian Relevance

Carbon monoxide poisoning is an OHIP-covered HBOT indication in Ontario. Canadian patients who survive CO poisoning should be evaluated for HBOT, including those presenting with neurological symptoms like vision loss.

Study Limitations

This is a single case report, so the rate of vision recovery with HBOT for CO-related blindness cannot be estimated.

This plain-language summary is generated with AI assistance and checked against the source abstract before publication. See our editorial policy.

Was this summary helpful?

Study Details

Study Type Case Report
Category Carbon Monoxide Poisoning
Source Pubmed
PubMed ID 38833305
Year Published 2024
Journal J Burn Care Res
MeSH Terms Humans; Male; Carbon Monoxide Poisoning; Adult; Hyperbaric Oxygenation; Magnetic Resonance Imaging; Blindness; Burns

Cite This Study

Share

This study relates to Carbon Monoxide Poisoning. Read the full clinical overview, the evidence base, and Canadian treatment access for this condition.

Find a Canadian Clinic Treating Carbon Monoxide Poisoning

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.

Last reviewed: March 19, 2026 | Reviewed by: Canada Hyperbarics Editorial Team | Editorial process | Research sources | Counts & methodology